SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-031478
Filing Date
2024-03-14
Accepted
2024-03-14 16:09:27
Documents
14
Period of Report
2024-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inab-20240314.htm   iXBRL 8-K 41800
2 EX-99.1 inab-ex99_1.htm EX-99.1 157122
3 GRAPHIC img75407775_0.jpg GRAPHIC 2489
  Complete submission text file 0000950170-24-031478.txt   332101

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inab-20240314.xsd EX-101.SCH 25963
15 EXTRACTED XBRL INSTANCE DOCUMENT inab-20240314_htm.xml XML 4926
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39692 | Film No.: 24750167
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)